Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain

Journal of General Internal Medicine

Volumn 32, Issue 3, 2017, Pages 291-295

  Behar, Emily ^a,b   Rowe, Christopher ^a   Santos, Glenn Milo ^a,b   Coffa, Diana ^b   Turner, Caitlin ^a   Santos, Nina C ^a   Coffin, Phillip O ^a,b  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

naloxone co prescription; opioid analgesics; opioid overdose; primary care

Indexed keywords

MORPHINE; NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ARTICLE; CALIFORNIA; CHRONIC PAIN; DRUG DEPENDENCE; DRUG OVERDOSE; DRUG SAFETY; FAMILY MEDICINE; HEALTH CARE PRACTICE; HEALTH CARE SURVEY; HUMAN; INTERNAL MEDICINE; INTERNIST; LONG TERM CARE; MEDICAL HISTORY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RESIDENT; SAFETY NET HOSPITAL; CLINICAL PRACTICE; CLINICAL TRIAL; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; MULTICENTER STUDY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; CHRONIC PAIN; DRUG OVERDOSE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; PHYSICIANS, PRIMARY CARE; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES;

EID: 84994234815     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-016-3911-z     Document Type: Article

References (17)

1. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: Final Data for 2013. Nat Vital Stat Syst. 2016;64(2):1–119.
2. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382.
3. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
4. Strang J. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths. Addiction. 2015;110(Suppl 2):27–35.
5. Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
6. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abuse. 2015;36(2):240–253.
7. Bartoszek M, Dragovich A, Algeo D, Sellars J. Operation OpioidSAFE: Executive Summary. Womack Army Medical Center: Fort Bragg, NC; 2012.
8. Su A, Brason FW 2nd, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(Suppl 2):S77–S85.
9. Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007;84(1):126–136.
10. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015;30(12):1837–1844.
11. Leece P, Orkin A, Shahin RM, Steele L. Can naloxone prescription and overdose training for opioid users work in family practice? Can Fam Physician. 2015;61(6):538–543.
12. Matheson C, Pflanz-Sinclair C, Aucott L, et al. Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:12.
13. Wilson JD, Spicyn N, Matson P, Alvanzo A, Feldman L. Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hopsital and clinic settings. Subst Abus. 2016;37(3):480–487.
14. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015;110(8):1301–1310.
15. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities. J Urban Health. 2015;92(4):758–772.
16. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. J Urban Health. 2016;93(1):117–130.
17. Coffin PO, Behar E, Rowe C, et al. Non-randomized intervention study of naloxone co-prescription for primary care patients on long-term opioid therapy for pain. Ann Intern Med 2016;165(4):245–252.